XML 45 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating activities:    
Net loss $ (17,137,000) $ (14,076,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value of rights from Private Placement 3,832,000 (1,582,000)
Change in fair value of notes payable 9,000 22,000
Non-cash stock-based compensation 1,240,000 3,854,000
Non-cash operating lease expense 472,000 739,000
Depreciation and amortization 0 9,000
Common stock issued for services 469,000 189,000
Gain on disposal of asset 0 (91,000)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (262,000) 338,000
Accounts payable 207,000 (2,941,000)
Accrued expenses and other current liabilities 150,000 (1,385,000)
Operating lease liability (547,000) (843,000)
Deferred revenue 0 (442,000)
Net cash used in operating activities (11,567,000) (16,209,000)
Investing activities:    
Proceeds from sale of property and equipment 0 331,000
Net cash provided by investing activities 0 331,000
Financing activities:    
Proceeds from Exclusivity Payments and advances 5,995,000 0
Proceeds from issuance of common stock and pre-funded warrants 500,000 8,561,000
Proceeds from exercise of warrants 2,000 30,000
Repayments of notes payable (150,000) 0
Repayments of finance lease liabilities 0 (123,000)
Net cash provided by financing activities 6,347,000 8,468,000
Net change in cash and restricted cash (5,220,000) (7,410,000)
Cash and restricted cash at beginning of year 5,858,000 13,268,000
Cash and restricted cash at end of year 638,000 5,858,000
Components of cash and restricted cash:    
Cash 634,000 5,783,000
Restricted cash 4,000 75,000
Total cash and restricted cash 638,000 5,858,000
Supplemental disclosure of cash flow information:    
Cash paid for interest 23,000 48,000
Supplemental disclosure of noncash investing and financing activities:    
Withholding to cover taxes from RSU vesting $ 0 $ 69,000